Latest News

Market Exclusive Biotech News & Analysis

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Just Took A Hit: Here’s Why And...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) just announced data from a phase 2 study of a drug called TV-45070. The data wasn't great and the company...

Teva Pharmaceutical Industries Ltd (NYSE:TEVA), Xenon Pharmaceuticals Inc (NASDAQ:XENE) Reveal TV-45070...

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Xenon Pharmaceuticals Inc (NASDAQ:XENE) announced yesterday that their mid-stage nerve pain drug, Topical TV-45070 failed to achieve its...